Evidence Generation: Evolution and Future of Integrated Evidence Planning

Life Sciences, Clinical Trials, Healthcare, Commercialization & HEOR,
  • Wednesday, May 22, 2024

It is increasingly important for the life sciences industry to adopt an integrated approach to planning, generating and managing the evidence required for the value of its innovations. Integrated evidence planning (IEP) is a framework that leverages an ensemble of different data sources, scientific methods and cross-functional expertise across a product’s life cycle to generate key information about its benefits, safety and value most effectively and efficiently.

In this webinar, the expert speaker will provide insights into functional and operational aspects of IEP and the rationale and benefits of IEP. They will discuss the evolution of IEP, future trends and how it meets different stakeholders’ requirements. Attendees will gain insights into the potential barriers to IEP and ways to overcome them, as well as the operational aspects of IEP such as the development, implementation and operationalization of IEP systems.

Join this webinar:

  • To understand the rationale for integrated evidence generation and the need for evidence beyond randomized controlled trials
  • To learn the evolution of IEP
  • To brainstorm on the challenges for IEP and potential solutions to overcome them
  • To decipher the architecture of IEP systems and processes involved in their development, implementation and operation
  • To form a forward-looking vision with regards to the emerging innovative trends in IEP


Won Chan Lee, Axtria – Ingenious Insights

Dr. Won Chan Lee, PhD, Principal and Practice Lead of HEOR/RWE Practice, Axtria – Ingenious Insights

Dr. Won Chan Lee has more than 20 years of experience in health economics and outcomes research, including integrated evidence strategic planning, RWD strategies and RWE studies, economic modeling, post-marketing studies and HRQL/PRO assessments. His research has resulted in more than 55 professional publications in top medical journals and more than 100 presentations at scientific venues, leading to enhanced patient access to health technology. At Axtria, he is Practice Lead of RWE, HEOR and Evidence Synthesis. Prior to Axtria, he had led RWE & HEOR functions at medical device and digital health technology firms and served as a principal consultant at premier consulting companies such as IQVIA, Evidera and Abt Associates. Dr. Lee earned his PhD in Health Economics at the Graduate Center of the City University of New York and his Master’s degree in Economics at the University of Grenoble, France.

Message Presenter
Chris Blanchette, Novo Nordisk

Chris Blanchette, PhD, Vice President, Clinical Data Science & Evidence, Novo Nordisk

Christopher Blanchette is Vice President of Clinical Data Science and Evidence at Novo Nordisk Inc. He is a clinical epidemiologist and health services researcher with extensive experience in leading research teams, departments and divisions over the last 20 years across clinical and observational research programs ranging from conducting cardiac anesthesiology clinical research to building economic models, conducting real world evidence and drawing insights on medical outcomes from real-world data in academic medical centers, research institutes, consulting firms as well as several pharmaceutical companies where he held global, US and field roles in health economics and outcomes research, data analytics and market access. In his current role, he leads over 50 data scientists, epidemiologists, health economists, public health scientists and health services researchers to assess the clinical, economic and humanistic outcomes associated with cardiometabolic disease progression and associated pharmaceutical use.   

Chris completed a PhD/MS in Pharmaceutical Health Services Research and Pharmacoepidemiology at the University of Maryland, MBA in Pharmaceutical Marketing at Saint Joseph’s University, post-graduate training in Clinical Research Management at Duke University and a MA in Sociology at the University of North Carolina at Charlotte.

Message Presenter

Shibani Pokras, Senior Director and Global Process Owner, Integrated Evidence Planning, GSK

Shibani Pokras is a seasoned leader in evidence strategy and planning, with 10 years of experience at GSK and 10 years of consulting experience in health economics and real world evidence (RWE). She has built new organizational capabilities at GSK and in consulting as Process and Product Owner. As the Global Process Owner of Integrated Evidence Planning at GSK, she is responsible for embedding a new framework for evidence strategy and planning across all therapy areas and lifecycle stages, with the aim of delivering value for patients, payers, physicians and regulators. Shibani and her team have successfully delivered almost 50 integrated evidence planning (IEP) workshops, changing the ways of working of over 1500 employees across global, region, and local evidence generating functions. She led her team to win the prestigious R&D Transformational Medicines & Vaccines Award in 2023 for their impact at GSK. Prior to this Shibani led and executed evidence strategies to address global stakeholder needs and evidence gaps in oncology cell and gene therapy, rare diseases, and maternal and neonatal health.

Message Presenter

Who Should Attend?

This webinar will appeal to professionals in the following fields:

  • Real-world evidence (RWE)
  • Health economics and outcomes research (HEOR)
  • Market access (value and access)
  • Research and development (R&D)
  • Medical Affairs
  • Data science
  • Biostatistics
  • Commercialization
  • Commercial operations
  • Market analytics and forecasting
  • Sales/Marketing
  • Epidemiology and drug safety
  • Clinical development
  • Patient engagement/patient centricity/patient reported outcomes

What You Will Learn

Attendees will gain insights into:

  • Functional and operational aspects of IEP
  • Rationale and benefits of IEP
  • Evolution of IEP, future trends and how it meets different stakeholders’ requirements
  • Potential barriers to IEP and ways to overcome them
  • Operational aspects of IEP including development, implementation and operationalization of IEP systems

Xtalks Partner


Axtria is a global provider of award-winning cloud software and data analytics to the Life Sciences industry. Axtria’s solutions are used to digitally transform the entire product commercialization process, driving sales growth and improving healthcare outcomes for patients. Our focus is on delivering solutions that help customers complete the journey from Data-to-Insights-to-Action and get superior returns from their sales and marketing investments.

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account